Scalable multiplex co-fractionation/mass spectrometry platform for accelerated protein interactome discovery.
Nature Communications
Havugimana, Pierre C PC; Goel, Raghuveera Kumar RK; Phanse, Sadhna S; Youssef, Ahmed A; Padhorny, Dzmitry D; Kotelnikov, Sergei S; Kozakov, Dima D; Emili, Andrew A
Phase I studies of vorinostat with ixazomib or pazopanib imply a role of antiangiogenesis-based therapy for TP53 mutant malignancies.
Scientific Reports
Wang, Yudong Y; Janku, Filip F; Piha-Paul, Sarina S; Hess, Kenneth K; Broaddus, Russell R; Liu, Lidong L; Shi, Naiyi N; Overman, Michael M; Kopetz, Scott S; Subbiah, Vivek V; Naing, Aung A; Hong, David D; Tsimberidou, Apostolia M AM; Karp, Daniel D; Yao, James J; Fu, Siqing S
Martelotto, Luciano G LG; Ng, Charlotte Ky CK; De Filippo, Maria R MR; Zhang, Yan Y; Piscuoglio, Salvatore S; Lim, Raymond S RS; Shen, Ronglai R; Norton, Larry L; Reis-Filho, Jorge S JS; Weigelt, Britta B